219750 — BTB Korea Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for BTB Korea Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	—	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	19,979	14,343	5,670	31,436	30,135
Cost of Revenue
Gross Profit	4,669	-1,188	767	7,101	7,784
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	31,445	36,831	13,750	30,096	29,395
Operating Profit	-11,466	-22,488	-8,080	1,340	741
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-16,723	-9,598	-12,115	2,041	31.2
Provision for Income Taxes
Net Income After Taxes	-16,830	-9,598	-12,115	1,667	-160
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-16,830	-9,742	-12,783	1,667	-161
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-16,830	-9,742	-12,783	1,667	-161
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-9,515	842	-23,675	38	0.085
Dividends per Share